Introduction {#s1}
============

Olfactory receptors (Ors) play a pivotal role in sensing volatile chemicals in the external environment. Although both vertebrate and invertebrate Ors possess a seven-transmembrane topology, mammalian Ors are G protein-coupled receptors, whereas insect Ors are heteromeric cation channel complexes that are directly gated by chemosignals, including general odorants and pheromones [@pone.0063774-Touhara1], [@pone.0063774-Sato1], [@pone.0063774-Wicher1]. Each insect Or comprises one type of variable ligand-binding subunit and a highly conserved Orco subunits [@pone.0063774-Nakagawa1], [@pone.0063774-Neuhaus1], [@pone.0063774-Benton1], [@pone.0063774-Larsson1]. For example, *cis*-jasmone, a volatile and a key attractant for the silkworm *Bombyx mori,* is recognized by BmOr-56-BmOrco complex [@pone.0063774-Tanaka1], but bombykol, the sex pheromone in silkmoths, is recognized by BmOr-1-BmOrco complex [@pone.0063774-Nakagawa1]. Although there was a debate as to the mechanism that the Or-Orco complexes function as ion channels [@pone.0063774-Sato1], [@pone.0063774-Wicher1], [@pone.0063774-Smart1], [@pone.0063774-Yao1], several recent studies have shown that both the ligand-selective Or subunit and the Orco co-receptor contributed to ion channel activity [@pone.0063774-Nichols1], [@pone.0063774-Jones1], [@pone.0063774-Pask1], [@pone.0063774-Nakagawa2]. Thus, every type of heteromeric complex exhibits specific, distinct ligand selectivity and distinct channel properties. Given that there are 60--400 potential ligand-binding Or genes in each insect species [@pone.0063774-Tanaka1], [@pone.0063774-Scott1], [@pone.0063774-Hill1], [@pone.0063774-Fox1], [@pone.0063774-Robertson1], [@pone.0063774-Wanner1], [@pone.0063774-Engsontia1], the insect Or complex represent a large family of ion-channel receptors.

Each type of Or subunit are thought to possess a unique odorant-, pheromone-, or DEET (an insect repellent)-binding site [@pone.0063774-Nichols2], [@pone.0063774-Pellegrino1], whereas the Orco subunit does not seem to possess ligand-binding activity; this subunit seems to function solely as a co-receptor that transports the complex to dendritic membranes [@pone.0063774-Nakagawa1], [@pone.0063774-Benton1], [@pone.0063774-Larsson1]. Recently, however, it has been reported that the Orco itself can form a functional channel that is activated by VUAA1, which is a non-volatile compound that possesses a purine structural motif [@pone.0063774-Jones1]. These observations indicate that multiple ligand-binding sites exist in each subunit of insect Or complex, and that the channel activity may be regulated by more chemicals than previously thought, including non-volatile compounds other than volatile odorants or pheromones.

Interestingly, cyclic nucleotides seem to participate in Or-mediated signaling in insects. Reportedly, stimulation of insect antennae with an odorant or pheromone *in vivo* causes an elevation of cyclic nucleotides; this finding also indicated that cyclic nucleotides are involved in insect chemosensory signaling [@pone.0063774-Ziegelberger1]. Wicher et al. has proposed that binding of odorants to the canonical Or subunit activates a Gα~s~ pathway that elevates the intracellular cAMP level, and that this elevation in intracellular cAMP modulates channel activity [@pone.0063774-Wicher1], [@pone.0063774-Sargsyan1]. However, in our previous study, no increase in intracellular cAMP level was observed upon ligand stimulation, and application of GDP-βS, an inhibitor of G-proteins, had no effect on responses of insect Ors [@pone.0063774-Sato1]. Therefore we concluded that cyclic nucleotides are not involved in the primary insect olfactory signal transduction. This conclusion was supported by the *in vivo* study showing mutant flies lacking G α proteins in OSNs exhibit normal odor-responses [@pone.0063774-Yao1]. However, we also found that the insect Or-Orco complex was marginally sensitive to two membrane-permeable cyclic nucleotide analogs, 8-Br-cGMP and 8-Br-cAMP, indicating the possibility that cyclic nucleotides can somehow modulate the activity of the Or-Orco complex [@pone.0063774-Sato1]. Thus, despite the hard efforts, the role of cyclic nucleotides in insect olfactory signal transduction has been not clear.

Here, we attempted to address the question of whether cyclic nucleotides affect insect Or function, and if so, to elucidate the mechanisms of action of these cyclic nucleotides to insect Ors. Rather surprisingly, we found that cyclic nucleotides non-competitively inhibited the response of the BmOr-1-BmOrco complex to bombykol and that these nucleotides acted via the extracellular surface of the plasma membrane. Our findings have intriguing implications for the role of cyclic nucleotides in pheromone detection in the silkmoth *Bombyx mori*.

Results {#s2}
=======

Cyclic Nucleotides Weakly Activate BmOr-1-BmOrco from the Extracellular Side {#s2a}
----------------------------------------------------------------------------

We have previously shown that HEK293T cells expressing BmOr-1-BmOrco or Or47a-Orco were weakly sensitive to extracellular applications of membrane-permeable cyclic nucleotide analogs, 8-Br-cGMP and 8-Br-cAMP [@pone.0063774-Sato1]. Because these cyclic nucleotide analogs were membrane-permeable, we could not determine whether these reagents acted on the Or-Orco complex via the extracellular or intracellular domain of the complex. To address this question, we applied cGMP, cAMP, db-cGMP, or db-cAMP to *Xenopus laevis* oocytes that expressed BmOr-1-BmOrco. cGMP and cAMP are not membrane-permeable molecules, but db-cGMP and db-cAMP are. The oocytes responded not only to the membrane-permeable cyclic nucleotides, but also to cGMP and cAMP ([**[Figure. 1A]{.ul}**](#pone-0063774-g001){ref-type="fig"}). None-injected oocytes did not show any response to these reagents ([**[Figure.1A]{.ul}**](#pone-0063774-g001){ref-type="fig"}). The average amplitudes of BmOr-1-BmOrco expressing oocytes in response to individual cyclic nucleotides (100 µM) were 4.7% to 18% of the amplitudes resulting from responses to bombykol (cGMP, 16±2.1%, cAMP, 18±2.1%, 8-Br-cGMP, 16±2.0%, 8-Br-cAMP, 9.9±1.3%, db-cGMP, 8.0±2.1%, db-cAMP, 4.7±0.4%). To obtain maximal responses, the reagents were applied for 30 sec. The responses were dose-dependent ([**[Figure. 1B, C]{.ul}**](#pone-0063774-g001){ref-type="fig"}).

![Cyclic nucleotides weakly activate the BmOr-1-BmOrco complex from outside of the cell.\
(A) Summary of the average responses of BmOr-1-BmOrco-injected oocytes (left) and none-injected oocytes (right) to various cyclic nucleotide reagents (100 µM). Each response was normalized by the response amplitude of BmOr-1-BmOrco-injected oocytes to 10 µM bombykol. The bar graphs show mean ± S.E.M. from 3--4 independent oocytes. (B) Representative current traces of oocytes expressing BmOr-1-BmOrco in response to bombykol and various concentrations of cyclic nucleotides. Bombykol was applied to the oocytes at the time indicated by the arrowhead (for 5 sec), and cyclic nucleotides were applied during the time indicated by colored square (for 30 sec), respectively. Concentrations of ligands were as follows: bombykol, 10 µM, cyclic nucleotides, 100 nM, 1 µM, 10 µM, 100 µM. (C) Dose-dependent responses of BmOr-1-BmOrco to cAMP (yellow) or cGMP (blue). Each point represents the mean current ± S.E.M. from 3 independent oocytes. Each response was normalized to the response to 10 µM bombykol. (D) Representative current traces of oocytes expressing rat olfactory cyclic nucleotide-gated channel complex (CNGA2+A4+B1b) in response to 8-Br-cGMP or cGMP (100 µM). n = 4. (E) Current-voltage relationships of oocytes expressing BmOr-1-BmOrco in response to bombykol (black), cGMP (blue), and cAMP (yellow).](pone.0063774.g001){#pone-0063774-g001}

To assess the membrane permeability of these reagents, we examined whether oocytes that expressed rat cyclic nucleotide-gated channels (CNGA2+A4+B1b), which has a cyclic nucleotide-binding site only in the intracellular domain [@pone.0063774-Varnum1], were sensitive to these cyclic nucleotide reagents. The oocytes that expressed the CNG channel responded to extracellular application of 8-Br-cGMP, which is membrane permeable, but not to membrane-impermeable cGMP ([**[Figure. 1D]{.ul}**](#pone-0063774-g001){ref-type="fig"}). These results indicated that the extracellular surface of the BmOr-1-BmOrco complex had a site that interacted with cyclic nucleotides or their analogs.

The current-voltage relationships of cyclic nucleotide-induced responses were similar to that of the bombykol-induced response, indicating that the same ion channel was involved in the response to cyclic nucleotides and to bombykol ([**[Figure. 1E]{.ul}**](#pone-0063774-g001){ref-type="fig"}). These results indicated that cyclic nucleotides functioned as weak agonists of the bombykol receptor.

We next examined whether other insect Ors were also sensitive to cyclic nucleotides and their analogs. Specifically, we tested the Or47a-Orco (*Drosophila melanogaster*) and AgOr2-AgOrco (*Anopheles gambiae*) complexes, which represented general odorant receptors [@pone.0063774-Sato1], and the OscaOr1-OscaOrco, OscaOr3-OscaOrco and OscaOr4-OscaOrco complexes (*Ostrinia scapulalis*), which represented pheromone receptors [@pone.0063774-Miura1], [@pone.0063774-Miura2]. We expressed each Or-Orco complex in *Xenopus* oocytes and treated these oocytes with each of the cyclic nucleotides, the two membrane-permeable and the two membrane-impermeable nucleotides. None of Or-Orco complex showed clear responses to any of the nucleotides, but Or47a-Orco and AgOr2-AgOrco each showed a marginal response to each nucleotide ([**[Figure. 2A, B]{.ul}**](#pone-0063774-g002){ref-type="fig"}). These results indicated that sensitivity to cyclic nucleotides is not a common feature of Or-Orco complexes.

![Responsiveness of various Or-Orco complexes to cyclic nucleotides.\
(A) Representative current traces of oocytes expressing various insect Or-Orco complex in response to their cognate ligands and cyclic nucleotide reagents. Pheromone/odorant was applied to the oocytes at the time indicated by the arrowhead (for 5 sec), and cyclic nucleotide reagent was applied during the time indicated by colored square (for 30 sec), respectively. Concentrations of ligands are as follows: *E*11--14:OH, 10 µM, *E*11--14:OAc, 10 µM, pentylacetate, 100 µM, 2-methylphenol, 100 µM, cyclic nucleotide reagents, 100 µM. (B) Summary of the average responses to cyclic nucleotide reagents. Each response was normalized to a response to the cognate ligand of each Or. The bar graphs show mean ± S.E.M. from 3--4 independent oocytes.](pone.0063774.g002){#pone-0063774-g002}

Cyclic Nucleotides Interact with the BmOr-1 Subunit of the Receptor {#s2b}
-------------------------------------------------------------------

We next determined whether the Or subunit or the Orco subunit interacted with the cyclic nucleotides. The cyclic nucleotide sensitivity was dependent on the composition of Or-Orco complex ([**[Figures. 1]{.ul}**](#pone-0063774-g001){ref-type="fig"} **[,]{.ul}** [**[2]{.ul}**](#pone-0063774-g002){ref-type="fig"} [)]{.ul}; therefore, we reasoned that we could determine which subunit was the target of the cyclic nucleotides by changing the subunit composition of the complex. Responses to cGMP were observed in oocytes expressing BmOr-1 and any member of the Orco family (BmOrco, Orco, AgOrco) ([**[Figure. 3A, B]{.ul}**](#pone-0063774-g003){ref-type="fig"}). On the other hand, oocytes that expressed BmOr-3-BmOrco (bombykal receptor [@pone.0063774-Nakagawa1]) or BmOr-56-BmOrco did not respond to cGMP ([**[Figure. 3A, B]{.ul}**](#pone-0063774-g003){ref-type="fig"}). These results indicated that cyclic nucleotide sensitivity was dependent on the canonical Or subunit of the Or-Orco complex. Oocytes that express only an Orco protein did not show any response to cyclic nucleotides, but oocytes injected with any Orco family member but BmOrco responded to VUAA1, which is an allosteric agonist of Orco complexes [@pone.0063774-Jones1] [(]{.ul} [**[Figure. 3C]{.ul}**](#pone-0063774-g003){ref-type="fig"}). Taken together, these findings indicated that cyclic nucleotides appeared to interact with the BmOr-1 subunit of the BmOr-1-BmOrco complex.

![Cyclic nucleotides interact with BmOr-1 subunit of the BmOr-1-BmOrco complex.\
(A) Representative current traces of oocytes expressing various combinations of the insect Or-Orco complex in response to their cognate ligand or cGMP. Odorant was applied to the oocytes at the time indicated by an arrowhead (for 5 sec), and cGMP was applied during the time indicated by colored square (for 30 sec), respectively. Concentrations of ligands were as follows: bombykol, 10 µM, bombykal, 3 µM, *cis*-Jasmone, 100 µM, cGMP, 100 µM. (B) Summary of the average response amplitudes of the Or-Orco complex to cGMP. The Y-axis is normalized to the response to their cognate ligand. The bar graphs represent mean ± S.E.M. from 3--4 independent oocytes. One-way ANOVA with Tukey's multiple comparison test, \*\*\*p\<0.001. (C) Representative current traces of oocytes expressing the Orco family alone in response to cyclic nucleotide reagents or VUAA1 (for 30 sec or 10 sec, respectively). All reagents were applied at the concentration of 100 µM.](pone.0063774.g003){#pone-0063774-g003}

Cyclic Nucleotides are Non-competitive Antagonists of BmOr-1-BmOrco {#s2c}
-------------------------------------------------------------------

In *Bombyx mori*, perfusion of db-cGMP into lymph of pheromone-receptive sensillum caused reduction of an electrical response to bombykol [@pone.0063774-Redkozubov1]. Therefore, we hypothesized that cyclic nucleotides might inhibit the response of the BmOr-1-BmOrco to bombykol. To assess this hypothesis, we applied bombykol to oocytes that expressed the BmOr-1-BmOrco complex in the presence of a 10-fold amount of cGMP or cAMP compared to that of bombykol. Cyclic nucleotides were applied during and before or after 10 seconds of bombykol application; therefore, we could distinguish between activation and inhibitory effects of the cyclic nucleotides ([**[Figure. 4A]{.ul}**](#pone-0063774-g004){ref-type="fig"}). Responses of oocytes that expressed BmOr-1-BmOrco to bombykol were significantly reduced in the presence of cGMP or cAMP ([**[Figure. 4A, B]{.ul}**](#pone-0063774-g004){ref-type="fig"}). The cyclic nucleotides inhibited the response of oocytes to bombykol in a dose-dependent manner; responses in nucleotide-treated oocytes were 10--25% of those in oocytes that were not treated with cyclic nucleotides. The IC~50~ value of the inhibition was 217 nM for cAMP ([**[Figure. 4C]{.ul}**](#pone-0063774-g004){ref-type="fig"}).

![Cyclic nucleotides non-competitively inhibit the response of BmOr-1-BmOrco to bombykol.\
(A) A representative current trace of an oocyte expressing BmOr-1-BmOrco as it responds to bombykol in the presence of 100 µM cGMP. Bombykol was applied to the oocyte at the time indicated by the arrowhead, and cGMP was applied during the time indicated by light blue square, respectively. The trace for the inhibition of a response to bombykol by cGMP is magnified in an inset figure wherein the response to cGMP is distinguished from that to bombykol in the presence of cGMP. (B) Summary of average responses of BmOr-1-BmOrco to 10 µM bombykol in the absence (+None) or presence (+cGMP, +cAMP) of cyclic nucleotides (100 µM). Each bar represents mean ± S.E.M. from 3--4 independent oocytes. The Y-axis is normalized to the response amplitude of 10 µM bombykol+None condition. Unpaired Student's t-test, \*\*\*p\<0.001 vs '+None'. (C) Dose-dependent inhibition of BmOr-1-BmOrco by cyclic nucleotides as a percentage of the response to 10 µM bombykol. Each point represents mean ± S.E.M. from 4 independent oocytes. The IC~50~ value is 217 nM. (D) Dose-response curves of responses of BmOr-1-BmOrco to bombykol in the absence or presence of 100 µM cyclic nucleotides. Each point represents mean ± S.E.M. from 4--5 independent oocytes. EC~50~ values are as follows: '+None', 8.2 µM, '+cGMP', 2.8 µM, '+cAMP', 2.7 µM.](pone.0063774.g004){#pone-0063774-g004}

We next sought to determine the mechanism by which nucleotides inhibited BmOr-1-BmOrco. Generally speaking, receptors are subject to one or both of two types of inhibition, competitive or non-competitive inhibition. In the case of competitive inhibition, a dose-response curve is shifted toward higher concentration but there is no change in the maximum response amplitude at the saturated concentration of agonists. In contrast, in the case of non-competitive inhibition, the curve is not shifted, but the maximum response amplitude decreases. In the presence of cyclic nucleotides, the maximum response amplitude of oocytes that expressed BmOr-1-BmOrco was reduced, and there was no change in the EC~50~ value (control: 8.2 µM,+cGMP: 2.8 µM,+cAMP: 2.7 µM) ([**[Figure. 4D]{.ul}**](#pone-0063774-g004){ref-type="fig"}). These changes were typical of non-competitive inhibition. Taken together, these results indicated that cyclic nucleotides bound to a site within BmOr-1 that was distinct from the bombykol binding site, and that these nucleotides acted as non-competitive antagonists for BmOr-1-BmOrco.

We next examined whether any Or-Orco other than BmOr-1-BmOrco was also inhibited by cyclic nucleotides. We expressed seven different Or-Orco complexes (i.e. BmOr-3-BmOrco, BmOr-56-BmOrco, Or47a-Orco, AgOr2-AgOrco, OscaOr1-OscaOrco, OscaOr3-OscaOrco, or OscaOr4-OscaOrco) individually in oocytes and applied a mixture of cognate odor/pheromone and cyclic nucleotide. None of these seven Or-Orco complexes was inhibited by cyclic nucleotides, indicating that the antagonistic effect of cyclic nucleotide is not a common feature of insect Or-Orcos ([**[Figure. 5]{.ul}**](#pone-0063774-g005){ref-type="fig"}).

![Cyclic nucleotides do not inhibit the responses of Or-Orco types other than BmOr-1-BmOrco.\
(A) Representative current traces of oocytes that each expressed a different Or-Orco complex; these oocytes were responding to their cognate ligands in the absence or presence of 100 µM cGMP. Odorant (100 µM *cis*-Jasmone, 100 µM pentylacetate, 100 µM 2-methylphenol) or pheromone (1 µM bombykol, 3 µM bombykal, 10 µM *E*11--14:OH, and 1 µM *E*11--14:OAc) was applied to the oocytes at the time indicated by the arrowhead, and cGMP was applied during the time indicated by light blue square. (B) Summary of average responses of Or-Orco to their cognate ligands in the absence (+None) or presence (+cGMP, +cAMP) of cyclic nucleotides (100 µM). Each bar represents mean ± S.E.M. from 3--4 independent oocytes. The Y-axis is normalized to the response amplitude of 10 µM bombykol+None condition. Unpaired Student's t-test, \*\*p\<0.01 vs '+None'.](pone.0063774.g005){#pone-0063774-g005}

Structure-activity Relationship of Weak Activation and Inhibition of BmOr-1-BmOrco by Nucleotide-related Compounds {#s2d}
------------------------------------------------------------------------------------------------------------------

Finally, we examined the structure-activity relationship of the responsiveness of BmOr-1-BmOrco using various nucleotide-related compounds, including two cyclic nucleotides (cGMP and cAMP) and five other structurally related chemicals (GTP, ATP, guanosine, adenosine, and D-(−)-ribose) ([**[Figure. 6A]{.ul}**](#pone-0063774-g006){ref-type="fig"}). Each compound, other than D-(−)-ribose, exhibited weak agonist activity ([**[Figure. 6B]{.ul}**](#pone-0063774-g006){ref-type="fig"}) and had an inhibitory effect on the response of BmOr-1-BmOrco to bombykol ([**[Figure. 6C]{.ul}**](#pone-0063774-g006){ref-type="fig"}). None-injected oocytes did not show any response to those reagents ([**[Figure. 6B]{.ul}**](#pone-0063774-g006){ref-type="fig"}). The inhibitory effects of GTP, ATP, guanosine, and adenosine were weaker than those of cGMP and cAMP ([**[Figure. 6C]{.ul}**](#pone-0063774-g006){ref-type="fig"}). These results indicated that the purine structure in the compounds, but not the ribose moiety, was crucial for interaction with BmOr-1-BmOrco complex.

![Structure-activity relationship of BmOr-1-BmOrco to cyclic nucleotides and related reagents.\
(A) Structural formulae of reagents examined in this assay. (B) Summary of the average responses of BmOr-1-BmOrco-injected oocytes (left) and none-injected oocytes (right) to various nucleotide-related reagents (100 µM). Each response was normalized to the response of BmOr-1-BmOrco-injected oocytes to 10 µM bombykol. Each bar represents mean ± S.E.M. from 3 independent oocytes. (C) Summary of inhibition of the response to 10 µM bombykol by various nucleotide-related reagents (100 µM). The Y-axis is normalized to the response to 10 µM bombykol. Each bar represents mean ± S.E.M. from 3 independent oocytes. One-way ANOVA with Tukey's multiple comparison test, \*\*p\<0.01, \*\*\*p\<0.001. (D) A model showing the mechanism of action of cyclic nucleotides to the bombykol receptor (BmOr-1-BmOrco) complex. Cyclic nucleotides modulate the activity of the complex by binding to the allosteric site in the extracellular domain of the BmOr-1 subunit.](pone.0063774.g006){#pone-0063774-g006}

Discussion {#s3}
==========

Here, we demonstrated that cyclic nucleotides and related compounds acted as non-competitive inhibitors of the bombykol receptor, BmOr-1-BmOrco. Although this sensitivity to nucleotides appears to be not common for all insect Or-Orco complexes, nucleotide-related compounds may play a role in the modulation of pheromone responsiveness in silkmoths. The binding site(s) for the compounds resides in the BmOr-1 subunit, and it is a rather surprising result that these inhibitory nucleotides interacted with the bombykol receptor on the extracellular surface of the plasma membrane ([**[Figure. 6D]{.ul}**](#pone-0063774-g006){ref-type="fig"}). Our results support the notion that insect Or channels possess multiple ligand binding sites in the canonical Or subunit and at least one site in the Orco subunit, and therefore, are positively and negatively regulated by multiple factors [@pone.0063774-Jones1], [@pone.0063774-Jones2], [@pone.0063774-Chen1].

Cyclic nucleotides have been proposed to function as intracellular second messengers in insect olfactory signal transduction. *Antheraea polyphemus* OSNs show electrical responses to cGMP from the intracellular side [@pone.0063774-Zufall1]. Furthermore, by using a heterologous expression system, it has been shown that cyclic nucleotides mediate insect olfactory signal transduction by binding to Orco subunit [@pone.0063774-Wicher1], [@pone.0063774-Sargsyan1]. Electrical responses to 8-Br-cAMP have been observed in whole-cell or inside-out patch membranes of HEK293 cells expressing Orco alone [@pone.0063774-Wicher1], [@pone.0063774-Sargsyan1]. Contrary to those reports, we showed that cyclic nucleotides bound to and activate the BmOr-1 subunit from the extracellular side and the Orco subunit was not involved in cyclic nucleotide sensitivities. Currently, we do not understand the reason for this apparent contradiction. Nonetheless, our results indicated that cyclic nucleotides have a previously unappreciated role as extracellular factors that modulate the function of the bombykol receptor. Similar phenomena that cAMP and cGMP modulate functions of proteins from outside of the cells are reported in some other biological systems [@pone.0063774-Cervetto1], [@pone.0063774-Hofer1], [@pone.0063774-Nascimento1]. Thus, it is fair to say that insect Ors are regulated by cyclic nucleotides, but the mode or mechanism of regulation appears to be different between species and between receptors. Although BmOr-1 is so far the sole pheromone receptor that possesses cyclic nucleotides sensitivity, there may be other pheromone receptors that can be modulated by cyclic nucleotides as well. It is of note that several groups have observed the pheromone-dependent rise in cGMP in trichoid sensilla of *Antheraea polyphemus* and *Manduca sexta* [@pone.0063774-Ziegelberger1], [@pone.0063774-Stengl1].

BmOr-1-BmOrco activity was modulated by various nucleotide-related compounds, but not by D-(−)-ribose. Although we could not test a lone purine base due to insolubility of these compounds, the structure-activity relationship study suggested that the purine base was crucial for the binding activity to BmOr-1-BmOrco. A purine consists of a pyrimidine ring fused to an imidazole ring. VUAA1 possess a pyridine ring and a triazoline skeleton [@pone.0063774-Jones1]. It is interesting to note that both purine and VUAA1 are nitrogen-containing compounds. This might be a common feature for compounds that regulate activity of insect Or complexes.

There are many proteins with functions that are regulated by cyclic nucleotides, including cyclic nucleotide-gated channels, cGMP- and cAMP-dependent protein kinases, and the *E. coli* catabolite gene activator protein (CAP) [@pone.0063774-Kaupp1], [@pone.0063774-Shabb1]. These proteins share amino acid sequences that are involved in the binding of cyclic nucleotides [@pone.0063774-Kaupp1], [@pone.0063774-Shabb1]. Neither BmOr-1 nor BmOrco possess the cyclic nucleotide binding sequence conserved in the conventional cyclic nucleotide-binding proteins. In this regard, the BmOr-1-BmOrco complex may be a novel type of cyclic nucleotide-binding protein.

Several groups have proposed that cyclic nucleotides are involved in adaptation of olfactory sensory neurons in moths. Perfusion of db-cGMP into sensillum lymph of olfactory sensilla attenuates the bombykol response in *Bombyx mori* [@pone.0063774-Redkozubov1]. Additionally, stimulation of male silkmoth antennae with bombykol reportedly causes a long-lasting (nearly 30 min) elevation of the cGMP level within either the soma of olfactory sensory neurons or the surrounding auxiliary cells [@pone.0063774-Ziegelberger1]. These cells synthesize and secrete various chemicals and proteins into sensillum lymph [@pone.0063774-Gnatzy1]; therefore, we hypothesize that cyclic nucleotides (or other nucleotides) are synthesized in the surrounding auxiliary cells and are secreted into lymph after the stimulation of sex pheromones. The activity of pheromone-sensitive OSNs of *Bombyx mori* may be suppressed as a result of inhibition of BmOr-1-BmOrco complex.

Our results suggest that the action of receptor modulation by cyclic nucleotides is different depending on the concentration. At concentrations between 10 nM and 10 µM, cAMP or cGMP acted as antagonists of 10 µM bombykol (IC~50~ = 217 nM), but these compounds function as weak agonists at higher than 10 µM. Unfortunately, it is not possible to know the exact concentration of bombykol in sensillum lymph when male moths are exposed to bombykol emitted from female moths. Furthermore, the time course of increases in the amount of cyclic nucleotides subsequently secreted in the lymph upon pheromone stimulation is unclear. Nonetheless, our results showed reasonable concentration-dependent kinetics such that, at a physiological concentration, cyclic nucleotides may act as an antagonist of the bombykol receptor rather than as an agonist.

We propose the intriguing possibility that the bombykol receptor was attenuated by nucleotide-related compounds that were acting on the extracellular surface of the plasma membrane. In the future, *in vivo* studies will be necessary to assess whether inhibition of the bombykol response that is mediated by these compounds is physiologically relevant. More precisely, the following three questions must be addressed. Does the perfusion of membrane-impermeable cyclic nucleotides into sensillum lymph of adult male *Bombyx mori* suppress the electrical and behavioral responses to bombykol? What is the physiological concentration of cyclic nucleotides in sensillum lymph of *Bombyx mori*? Is the amount of cyclic nucleotides elevated or reduced in some specific physiological timing? Answers to these questions will provide us with information on the meaning and the evolutional significance of the cyclic nucleotide sensitivity of the pheromone receptor in silkmoths.

Materials and Methods {#s4}
=====================

Odorants and Pheromones {#s4a}
-----------------------

Bombykol and bombykal were synthesized as previously described [@pone.0063774-Sakurai1]. *E*11--14:OAc and *E*11--14:OH were obtained from Pherobank (Wageningen, The Netherlands). VUAA1 was kindly provided by Dr. Leslie Vosshall (Rockefeller Univ.). Stock solutions of these reagents were prepared in DMSO (bombykol and bombykal: 30 mM, *E*11--14:OAc and *E*11--14:OH: 300 mM, VUAA1∶100 mM), and stored at −20°C. These stocks were diluted prior to use in experiments. Pentylacetate and 2-methylphenol were purchased from Tokyo Kasei (Tokyo, Japan) and were directly diluted into a control standard solution (115 mM NaCl, 2.5 mM KCl, 1.8 mM BaCl~2~, and 10 mM HEPES, titrated to pH 7.2 with NaOH) at a final working concentration of 10 or 100 µM. All cyclic nucleotide reagents and related compounds were purchased from Sigma-Aldrich (St. Louis, MO, USA) and were directly diluted into a control standard solution.

Receptor Expression in *Xenopus laevis* Oocytes and Two-electrode Voltage-clamp Recording {#s4b}
-----------------------------------------------------------------------------------------

Stage V to VII oocytes were treated with 2 mg/ml of collagenase B (Roche Diagnostics, Tokyo, Japan) in Ca^2+^-free saline solution (82.5 mM NaCl, 2 mM KCl, 1 mM MgCl~2~, and 5 mM HEPES, pH 7.5) for 1 to 2 h at room temperature. Each cRNA was synthesized from a linearized modified pSPUTK vector [@pone.0063774-Katada1]. For the experiments using insect Or-Orco complexes, oocytes were microinjected with 25 ng of canonical Or cRNA (BmOr-1, BmOr-3, BmOr-56, OscaOr1, OscaOr3, OscaOr4, Or47a, or AgOr2) and 25 ng of the Orco family cRNA (BmOrco, Orco, or AgOrco). For the experiments using oocytes expressing Orco family alone, the oocytes were microinjected with 50 ng of the Orco family cRNA. For the control experiment using rat CNG channel, oocytes were microinjected with 25 ng of CNGA2 cRNA and 12.5 ng of CNGA4 and CNGB1b cRNA. Injected oocytes were incubated for 3--4 days at 18°C in bath solution supplemented with 10 µg/ml of penicillin and streptomycin.

Whole-cell currents were recorded using the two-electrode voltage-clamp technique. Intracellular glass electrodes were filled with 3 M KCl. Signals were amplified with an OC-725C amplifier (Warner Instruments, Hamden, CT, USA), low-pass filtered at 50 Hz and digitized at 1 kHz. The control standard solution contained 115 mM NaCl, 2.5 mM KCl, 1.8 mM BaCl~2~, and 10 mM HEPES, and titrated to pH 7.2 with NaOH. For the control that involved the rat CNG channel, BaCl~2~ was removed from the solution, because divalent cations inhibit the response of CNG channels [@pone.0063774-Park1].

The current-voltage relationship was measured by changing membrane potential from −80 mV to +50 mV using voltage-ramp and analyzed by IgorPro software (WaveMetrics, Portland, OR, USA). Ligands were delivered through the superfusing bath solution via a silicon tube that was connected to a computer-driven solenoid valve. Data acquisition and analysis were carried out with Digidata1322A (Axon instruments, Foster city, CA, USA) and pCLAMP software (Axon instruments, Foster city, CA, USA).

Calculation of Agonist or Antagonist Activity of Cyclic Nucleotides {#s4c}
-------------------------------------------------------------------

Agonistic activities of cyclic nucleotides ([Figures. 1A, 1D](#pone-0063774-g001){ref-type="fig"}, [2B](#pone-0063774-g002){ref-type="fig"}, [3B](#pone-0063774-g003){ref-type="fig"}, [6B](#pone-0063774-g006){ref-type="fig"}) were calculated as relative amplitude compared to the amplitude in response to first application of a cognate ligand of each pheromone/olfactory receptor in the same oocytes. Antagonistic activities of cyclic nucleotides (responses to cognate ligands in the presence of cyclic nucleotides that are shown in [Figures. 4B](#pone-0063774-g004){ref-type="fig"}, [5B](#pone-0063774-g005){ref-type="fig"}, [6C](#pone-0063774-g006){ref-type="fig"}) were calculated as relative amplitude compared to the response amplitude to cognate ligands in the absence of cyclic nucleotides. To avoid the overestimation of inhibitory effect due to desensitization of odor responses by repeated odor application,+None and +\[cyclic nucleotide\] were respectively calculated from independent ooyctes.
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